Accounting reportsPreviously
|
Name | VETERINARNAYA KLINIKA DRUG , OOO |
|---|
INN | 6316058784 |
|---|
KPP | 631701001 |
|---|
OGRN | 1026301180971 |
|---|
OKPO | 51884331 |
|---|
Address | 443099, Samarskaya Oblast', g. Samara, ul. Kuybysheva, d. D. 57, of. NEZH. ZDAN LITERA DD1, OFIS 1 |
|---|
Phone | 32-97-97 |
|---|
Fax | 70-81-31 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 75.00 | Core activity | veterinary activities | | 46.38.22 | Additional activity | Wholesale trade pet food | | 46.45.1 | Additional activity | Wholesale trade of perfumes and cosmetics, except soap | | All types of activities | | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | | 47.29.39 | Additional activity | Retail trade of other food products in specialized stores, not included in other categories | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | 47.75.1 | Additional activity | Retail sale of cosmetic and toilet articles in specialised stores | | 47.76.2 | Additional activity | Flowers Retail | | 47.78.9 | Additional activity | Other retail sale nec (not in stores) | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 04.03.2003 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram po Oktyabr'skomu rayonu goroda Samary |
|---|
|
VK DRUG , OOO (Samara Oblast; INN 6316058784) was registered on 4 Mar 2003. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of VK DRUG , OOO - Limited liability companies. Form of ownership of VK DRUG , OOO - Combined Russian property with a federal property share. Principal activities of VK DRUG , OOO: veterinary activities (75.00), wholesale trade pet food (46.38.22), wholesale trade of perfumes and cosmetics, except soap (46.45.1). |
Economic indicators2023
Net profit (RAS) of VK DRUG , OOO grew over 2023 1.65 times to 7.06 million RUB from 4.27 million RUB over 2022, the company informed. Revenue increased in the accounting period by 1.13% to 75.19 million RUB from 74.34 million RUB over 2022; cost of goods sold decreased by 3.01% to 65.34 million RUB from 67.37 million RUB; sales profit went up by 41.19% to 9.84 million RUB from 6.97 million RUB. 2022
Net profit (RAS) of VK DRUG , OOO dropped in 2022 by 22.96% to 4.27 million RUB from 5.55 million RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 10.77% to 74.34 million RUB from 67.11 million RUB over 2021; cost of goods sold grew by 14.04% to 67.37 million RUB from 59.08 million RUB; sales profit fell by 13.28% to 6.97 million RUB from 8.04 million RUB. 2021
Net profit (RAS) of VK DRUG , OOO grew over 2021 1.57 times to 5.55 million RUB from 3.54 million RUB over 2020, the company informed. Revenue remained in the accounting period at the same level and made up 67.11 million RUB compared to 67.27 million RUB 67.27 million RUB. 2020
Net profit (RAS) of VK DRUG , OOO dropped in 2020 by 13.05% to 3.54 million RUB from 4.07 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 24.68% to 67.27 million RUB from 53.96 million RUB over 2019. 2019
Net profit (RAS) of VK DRUG , OOO made up 4.06 million RUB over 2019 compared to net loss of 60.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 36.67% to 53.96 million RUB from 39.48 million RUB over 2018. 2018
Net loss (RAS) of VK DRUG , OOO dropped over 2018 81.47 times to 60.00 thousand RUB from 4.89 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 46.63% to 39.48 million RUB from 26.93 million RUB over 2017; cost of goods sold grew by 24.19% to 39.14 million RUB from 31.52 million RUB; sales profit made up 336.00 thousand RUB compared to sales loss of 4.59 million RUB. 2017
Net loss (RAS) of VK DRUG , OOO increased 6.74 times to 5.64 million RUB from 837.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 1.35% to 26.93 million RUB from 26.57 million RUB over 2016; cost of goods sold grew by 18.53% to 31.80 million RUB from 26.83 million RUB; sales loss grew 18.47 times to 4.88 million RUB from 264.00 thousand RUB. 2016
Net loss (RAS) of VK DRUG , OOO increased 5.07 times to 837.00 thousand RUB from 165.00 thousand RUB over 2015, the company informed. Revenue decreased in the accounting period by 16.09% to 26.57 million RUB from 31.66 million RUB in 2015; cost of goods sold decreased by 11.31% to 26.83 million RUB from 30.25 million RUB; sales loss made up 264.00 thousand RUB compared to sales profit of 1.41 million RUB. 2014
Net loss (RAS) of VK DRUG, OOO increased 2.62 times to 4.27 million RUB from 1.63 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 20.40% to 24.66 million RUB from 30.98 million RUB in 2013; cost of goods sold decreased by 10.71% to 14.33 million RUB from 16.05 million RUB; sales loss grew 2.95 times to 3.82 million RUB from 1.30 million RUB. 2013
Net loss (RA) of VK DRUG, OOO made up 1.63 million RUB over 2013 compared to net profit of 3.01 million RUB over 2012, the company informed. Revenue decreased in the accounting period by 4.17% to 30.98 million RUB from 32.33 million RUB in 2012; cost of goods sold grew by 2.02% to 16.05 million RUB from 15.73 million RUB; sales loss made up 1.29 million RUB compared to sales profit of 2.68 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|